26,877
Participants
Start Date
February 16, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
December 31, 2026
Genome Informed Risk Assessment (GIRA) report
A Genome Informed Risk Assessment (GIRA) report that combines genetic (monogenic risks and polygenic risk scores), family history, and clinical risk information from participants.
Mount Sinai, New York
Columbia University, New York
Children's Hospital of Philadelphia, Philadelphia
University of Alabama Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Cincinnati Children's Hospital Medical Center, Cincinnati
Mayo Clinic, Rochester
Northwestern, Chicago
Mountain Park Health Center, Tempe
University of Washington, Seattle
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Vanderbilt University Medical Center
OTHER